Analysis of BRCA1 and BRCA2 mutations in Brazilian breast cancer patients with positive family history
Keywords:
Breast neoplasms, Hereditary diseases, BRCA1 gene, BRCA2 gene, Base sequenceAbstract
CONTEXT AND OBJECTIVE: BRCA1 and BRCA2 are the two principal hereditary breast cancer susceptibility genes, and the prevalence of their mutations among Brazilian women is unknown. The objective was to detect BRCA1 and BRCA2 mutations in Brazilian patients with breast cancer, so as to establish genetic profiles. DESIGN AND SETTING: Cross-sectional study, in Centro de Atenção Integral à Saúde da Mulher, Universidade Estadual de Campinas, Brazil, and Institute of Pathology and Molecular Immunology, University of Porto, Portugal. METHODS: Thirty-one breast cancer patients with positive family history (criteria from the Breast Cancer Linkage Consortium) were studied, and genomic DNA was extracted from peripheral blood. Single-strand conformation polymorphism was used for the analysis of exons 2, 3, 5, and 20 of BRCA1. Cases showing PCR products with abnormal bands were sequenced. Exon 11 of BRCA1 and exons 10 and 11 of BRCA2 were directly sequenced in both directions. RESULTS: Four mutations were detected: one in BRCA1 and three in BRCA2. The BRCA1 muta- tion is a frameshift located at codon 1756 of exon 20: 5382 ins C. Two BRCA2 mutations were nonsense mutations located at exon 11: S2219X and the other was an unclassified vari- ant located at exon 11: C1290Y. CONCLUSION: The BRCA1 or BRCA2 mutation prevalence found among women with breast cancer and such family history was 13% (4/31). Larger studies are needed to establish the significance of BRCA mutations among Brazilian women and the prevalence of specific mutations.
Downloads
References
Rahman N, Stratton MR. The genetics of breast cancer suscep- tibility. Annu Rev Genet. 1998;32:95-121.
Bertwistle D, Ashworth A. Functions of BRCA1 and BRCA2 genes. Curr Opin Genet Dev. 1998;8(1):14-20.
Narod SA, Feunteun J, Lynch HT, et al. Familial breast- ovarian cancer locus on chromosome 17q12-q23. Lancet. 1991;338(8759):82-3.
Lynch HT, Watson P, Conway TA, Lynch JF. Clinical/genetic features in hereditary breast cancer. Breast Cancer Res Treat. 1990;15(2):63-71.
Easton DF, Bishop DT, Ford D, Crockford GP. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 1993;52(4):678-701.
Andersen TI. Genetic heterogeneity in breast cancer susceptibil- ity. Acta Oncol. 1996;35(4):407-10.
Ellisen LW, Haber DA. Hereditary breast cancer. Annu Rev Med. 1998;49:425-36.
Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA. Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer. 1997;71(5):800-9.
Brody LC, Biesecker BB. Breast cancer susceptibil- ity genes. BRCA1 and BRCA2. Medicine (Baltimore). 1998;77(3):208-26.
Hall JM, Lee MK, Newman B, et al. Linkage of early-on- set familial breast cancer to chromosome 17q21. Science. 1990;250(4988):1684-9.
Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266(5182):66-71.
Wooster R, Neuhausen SL, Mangion J, et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science. 1994;265(5181):2088-90.
Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995;378 (6559):789-92.
National Human Genome Research Institute. National Institutes of Health. An open access on-line breast cancer mutation data base. An International Collaborative Effort hosted by NHGRI. Available from URL: http://research.nhgri.nih.gov/bic/. Ac- cessed in 2005 (Jun 06)
Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium. Lancet. 1997;349(9064):1505-10.
Sambrook J, Fritsch ET, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. New York: Cold Spring Harbor Laboratory Press; 1989.
Struewing JP, Hartge P, Wacholder S, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med. 1997;336(20):1401-8.
Koifman S, Jorge Koifman R. Breast cancer mortality among Ashkenazi Jewish women in São Paulo and Porto Alegre, Brazil. Breast Cancer Res. 2001;3(4):270-5.
Duran M, Esteban-Cardeñosa E, Velasco E, Infante M, Miner C. Mutational analysis of BRCA2 in Spanish breast cancer patients from Castilla-Leon: identification of four novel truncating mutations. Hum Mutat. 2003;21(4):448.
Schmitt FC, Reis Filho JS, Milanezi F, et al. Patología del cáncer de mama hereditario. Rev Senología y Patol Mam. 2001;14(1):29-35.
Jara L, Ampuero S, Seccia L, et al. Frecuencia de la mutación 185de- lAG en el gen BRCA1 en mujeres chilenas sanas con antecedentes familiares de cáncer de mama. Frequency of the 185delAG muta- tion in the BRCA1 gene in Chilean healthy women with family history of breast cancer]. Rev Med Chil. 2002;130(10):1113-23.
Soares R, Amendoeira I, Monteiro P, et al. BRCA1 mutation analysis in a Portuguese population with early-onset breast and/or ovarian cancer. Disease Markers. 1999;15:93.
Duarte F, Cameselle-Teijeiro JF, Soares R, et al. Análisis de mu- taciones en los genes BRCA1 y BRCA2 en pacientes con cáncer de mama y ovario del norte de Portugal y Galicia. Analysis of mutations in genes BRCA1 and BRCA2 among patients with breast and ovarian cancer in northern Portugal and Galicia]. Rev Clin Esp. 2002;202(5):259-63.
